The “Determining new medicine-targets, biological, physical and chemical analysis of and development of drug candidate synthetic and natural solutions for mitochondrial diseases” project has received funding (a total of 1.2 billion Hungarian forints) for four more years within the framework of the 2021 Health sub-program of the National Office of Research, Development, and Innovation’s Thematic Programme of Excellence.
“The research and change of function with various solutions of the unit responsible for the energy production of human cells, the mitochondria, is important because many diseases are caused by the faulty function of these cell elements. As with other similar complex programs, our project also requires the cooperation of a wide scale of researchers: within the scope of the 2021 Thematic Programme of Excellence, 100 researchers who have already achieved excellent results from the Medical School, the Faculty of Natural Sciences, the Faculty of Pharmacy and the Clinical Centre are participating.” – summarised the professional content of the project dr. László Kollár, professor at the University of Pécs, the head of the project.
As he said, the research includes everything from high efficacy, environmentally friendly synthesis and all-encompassing description using chemical and physical methods of new solutions, to biochemical research and clinical trials.
“The social effects of long-term research can be significant, since we have validated new targets for high mortality, today often uncurable diseases; we have also identified synthetic and non-toxic plant-based polyphenol solutions that have an effect on these diseases. The social use of our results is not only shown in how many lives these new therapy methods can lengthen or save, but in some cases we see a chance for exchanging earlier, highly expensive treatment methods for much more cost-effective alternatives.” – emphasised the professor.
Source:
UP